{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:48:34Z","timestamp":1792115314629,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.diabres.2022.109825","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:16:39Z","timestamp":1646824599000},"page":"109825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Clinical and economic outcomes of continuous glucose monitoring system (CGMS) in patients with diabetes mellitus: A systematic literature review"],"prefix":"10.1016","volume":"186","author":[{"given":"Aditi","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smit","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.diabres.2022.109825_b0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diabres.2010.01.026","article-title":"Global healthcare expenditure on diabetes for 2010 and 2030","volume":"87","author":"Zhang","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.diabres.2022.109825_b0010","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109825_b0015","unstructured":"International Diabetes Federation. IDF Diabetes Atlas. Available from: https:\/\/www.diabetesatlas.org\/upload\/resources\/material\/20200302_133351_IDFATLAS9e-final-web.pdf [accessed August 17, 2021]."},{"issue":"7","key":"10.1016\/j.diabres.2022.109825_b0020","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.2337\/dc16-0541","article-title":"NIH Precision Medicine Initiative: Implications for Diabetes Research","volume":"39","author":"Fradkin","year":"2016","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2022.109825_b0025","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s13300-018-0499-9","article-title":"Blood Glucose Monitoring and Its Determinants in Diabetic Patients: A Cross-Sectional Study in Shandong","volume":"9","author":"Raoufi","year":"2018","journal-title":"China Diabetes Ther"},{"issue":"4","key":"10.1016\/j.diabres.2022.109825_b0030","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/s19040800","article-title":"The progress of glucose monitoring\u2014A review of invasive to minimally and non-invasive techniques, devices and sensors","volume":"19","author":"Villena Gonzales","year":"2019","journal-title":"Sensors"},{"issue":"9","key":"10.1016\/j.diabres.2022.109825_b0035","article-title":"Continuous Glucose Monitoring Versus Self-monitoring of Blood Glucose in Type 2 Diabetes Mellitus: A Systematic Review with Meta-analysis","volume":"11","author":"Janapala","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.diabres.2022.109825_b0040","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Continuous Glucose Monitoring. Available from: https:\/\/www.niddk.nih.gov\/health-information\/diabetes\/overview\/managing-diabetes\/continuous-glucose-monitoring [accessed August 17, 2021]."},{"issue":"8","key":"10.1016\/j.diabres.2022.109825_b0045","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s00125-012-2580-7","article-title":"Regulation of medical devices used in diabetology in Europe: Time for reform?","volume":"55","author":"Boulton","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.109825_b0050","unstructured":"USFDA. USFDA Product Classification- invasive glucose sensor. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfPCD\/classification.cfm?ID=MDS [accessed August 17, 2021]."},{"key":"10.1016\/j.diabres.2022.109825_b0055","unstructured":"USFDA. USFDA Product Classification- hospital CGMS. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpcd\/classification.cfm?id=682 [accessed August 17, 2021]."},{"key":"10.1016\/j.diabres.2022.109825_b0060","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Brit Med J"},{"issue":"10","key":"10.1016\/j.diabres.2022.109825_b0065","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/bios10100138","article-title":"Accuracy of the Dexcom G6 Glucose Sensor during Aerobic, Resistance, and Interval Exercise in Adults with Type 1 Diabetes","volume":"10","author":"Guillot","year":"2020","journal-title":"Biosensors (Basel)"},{"issue":"11","key":"10.1016\/j.diabres.2022.109825_b0070","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.2337\/dc20-0112","article-title":"Real-time CGM is superior to flash glucose monitoring for glucose control in type 1 diabetes: the CORRIDA randomized controlled trial","volume":"43","author":"H\u00e1skov\u00e1","year":"2020","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.diabres.2022.109825_b0075","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/dom.13835","article-title":"Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: A secondary outcome analysis of a randomized crossover trial","volume":"21","author":"Moser","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10.1016\/j.diabres.2022.109825_b0080","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2337\/dc19-2527","article-title":"Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes","volume":"43","author":"Scott","year":"2020","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.diabres.2022.109825_b0085","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2337\/dc20-0736","article-title":"Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA(1c) in a Multiethnic Cohort of Adolescents and Young Adults With Type 1 Diabetes: The MILLENNIALS Study","volume":"43","author":"Thabit","year":"2020","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2022.109825_b0090","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/1932296819867688","article-title":"Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes","volume":"14","author":"Avari","year":"2020","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"10.1016\/j.diabres.2022.109825_b0095","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/dc20-1060","article-title":"A Randomized Clinical Trial Assessing Continuous Glucose Monitoring (CGM) Use With Standardized Education With or Without a Family Behavioral Intervention Compared With Fingerstick Blood Glucose Monitoring in Very Young Children With Type 1 Diabetes","volume":"44","author":"Laffel","year":"2021","journal-title":"Diabetes Care"},{"issue":"10128","key":"10.1016\/j.diabres.2022.109825_b0100","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(18)30297-6","article-title":"Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial","volume":"391","author":"Heinemann","year":"2018","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.diabres.2022.109825_b0105","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.2020.6940","article-title":"Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial","volume":"323","author":"Laffel","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.diabres.2022.109825_b0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/dme.13561","article-title":"A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia","volume":"35","author":"Reddy","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2022.109825_b0115","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2147\/DMSO.S299070","article-title":"Effectiveness of a WeChat Combined Continuous Flash Glucose Monitoring System on Glycemic Control in Juvenile Type 1 Diabetes Mellitus Management: Randomized Controlled Trial","volume":"14","author":"Xu","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"4","key":"10.1016\/j.diabres.2022.109825_b0120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1479164119827456","article-title":"Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial","volume":"16","author":"Ajjan","year":"2019","journal-title":"Diab Vasc Dis Res"},{"issue":"1","key":"10.1016\/j.diabres.2022.109825_b0125","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-021-00657-0","article-title":"Effects of intermittently scanned continuous glucose monitoring on blood glucose control and the production of urinary ketone bodies in pregestational diabetes mellitus","volume":"13","author":"Li","year":"2021","journal-title":"Diabetol Metab Syndr"},{"issue":"22","key":"10.1016\/j.diabres.2022.109825_b0130","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.2021.7444","article-title":"Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial","volume":"325","author":"Martens","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.diabres.2022.109825_b0135","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00125-017-4527-5","article-title":"Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial","volume":"61","author":"Oskarsson","year":"2018","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.diabres.2022.109825_b0140","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/dme.13649","article-title":"Continuous glucose monitoring results in lower HbA1c in Malaysian women with insulin-treated gestational diabetes: a randomized controlled trial","volume":"35","author":"Paramasivam","year":"2018","journal-title":"Diabet Med"},{"issue":"23","key":"10.1016\/j.diabres.2022.109825_b0145","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2020.6928","article-title":"Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial","volume":"323","author":"Pratley","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.diabres.2022.109825_b0150","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s13300-021-01086-y","article-title":"Episodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial","volume":"12","author":"Price","year":"2021","journal-title":"Diabetes Ther"},{"issue":"1","key":"10.1016\/j.diabres.2022.109825_b0155","doi-asserted-by":"crossref","first-page":"e001115","DOI":"10.1136\/bmjdrc-2019-001115","article-title":"Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial","volume":"8","author":"Wada","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"2","key":"10.1016\/j.diabres.2022.109825_b0160","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jdi.12699","article-title":"Performance of a new real-time continuous glucose monitoring system: A multicenter pilot study","volume":"9","author":"Zhou","year":"2018","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.diabres.2022.109825_b0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.diabres.2018.10.005","article-title":"Continuous glucose monitoring use and glucose variability in pre-school children with type 1 diabetes","volume":"147","author":"Dovc","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.diabres.2022.109825_b0170","first-page":"A07190404","article-title":"A pragmatic real-life study of flash glucose monitoring versus self-monitoring of blood glucose","volume":"67","author":"Greve","year":"2020","journal-title":"Dan Med J"},{"issue":"22","key":"10.1016\/j.diabres.2022.109825_b0175","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1001\/jama.2021.6530","article-title":"Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes","volume":"325","author":"Karter","year":"2021","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.diabres.2022.109825_b0180","first-page":"556","article-title":"Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion","volume":"65","author":"Moreno-Fernandez","year":"2018","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"7","key":"10.1016\/j.diabres.2022.109825_b0185","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00125-021-05437-z","article-title":"Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls","volume":"64","author":"Nathanson","year":"2021","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.diabres.2022.109825_b0190","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/dia.2018.0339","article-title":"Flash Glucose Monitoring Accepted in Daily Life of Children and Adolescents with Type 1 Diabetes and Reduction of Severe Hypoglycemia in Real-Life Use","volume":"21","author":"Messaaoui","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"10.1016\/j.diabres.2022.109825_b0195","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/dc19-1610","article-title":"Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study","volume":"43","author":"Charleer","year":"2020","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.diabres.2022.109825_b0200","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/pedi.13128","article-title":"Intermittently scanned continuous glucose monitoring is associated with high satisfaction but increased HbA1c and weight in well-controlled youth with type 1 diabetes","volume":"21","author":"Charleer","year":"2020","journal-title":"Pediatric Diabetes"},{"issue":"4","key":"10.1016\/j.diabres.2022.109825_b0205","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/pedi.12996","article-title":"Changing costs of type 1 diabetes care among US children and adolescents","volume":"21","author":"Crossen","year":"2020","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"10.1016\/j.diabres.2022.109825_b0210","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/1932296818777265","article-title":"Health Care Costs, Hospital Admissions, and Glycemic Control Using a Standalone, Real-Time, Continuous Glucose Monitoring System in Commercially Insured Patients With Type 1 Diabetes","volume":"12","author":"Gill","year":"2018","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"10.1016\/j.diabres.2022.109825_b0215","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/1932296820920909","article-title":"Patient Controlled, Off-label Use of Continuous Glucose Monitoring: Real-World Medical Costs and Effects of Patient Controlled Sensor Augmented Pump Therapy in Adult Patients Type 1 Diabetes","volume":"15","author":"Hidefj\u00e4ll","year":"2021","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"10.1016\/j.diabres.2022.109825_b0220","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/1932296817693253","article-title":"Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization","volume":"11","author":"Parkin","year":"2017","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"10.1016\/j.diabres.2022.109825_b0225","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14518","article-title":"The effects of continuous glucose monitoring system on patient outcomes and associated costs in a real-world setting","volume":"38","author":"Triki","year":"2021","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.diabres.2022.109825_b0230","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3355","article-title":"Impact of flash glucose monitoring on glucose control and hospitalization in type 1 diabetes: A nationwide cohort study","volume":"37","author":"Tsur","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"10.1016\/j.diabres.2022.109825_b0235","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00125-019-4894-1","article-title":"Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes","volume":"62","author":"Tyndall","year":"2019","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.diabres.2022.109825_b0240","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/13696998.2017.1390474","article-title":"Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab data","volume":"21","author":"Sierra","year":"2018","journal-title":"J Med Econ"},{"issue":"9","key":"10.1016\/j.diabres.2022.109825_b0245","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.2337\/dc20-0738","article-title":"Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit","volume":"43","author":"Deshmukh","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109825_b0250","unstructured":"FITTER. Helping to achieve HbA1c targets. Available from: https:\/\/www.fitter4diabetes.com\/pages\/helping-to-achieve-hba1c-targets [accessed August 20, 2021]."},{"key":"10.1016\/j.diabres.2022.109825_b0255","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fendo.2020.00370","article-title":"Vascular Complication in Adolescents With Diabetes Mellitus","volume":"11","author":"Graves","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.diabres.2022.109825_b0260","doi-asserted-by":"crossref","first-page":"e001092","DOI":"10.1136\/bmjdrc-2019-001092","article-title":"Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis","volume":"8","author":"Castellana","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"4","key":"10.1016\/j.diabres.2022.109825_b0265","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00592-020-01589-3","article-title":"Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials","volume":"58","author":"Dicembrini","year":"2021","journal-title":"Acta Diabetol"},{"issue":"5","key":"10.1016\/j.diabres.2022.109825_b0270","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2337\/dc19-1459","article-title":"Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials","volume":"43","author":"Maiorino","year":"2020","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabres.2022.109825_b0275","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/dia.2018.0177","article-title":"The Effectiveness of Continuous Glucose Monitoring in Patients with Type 2 Diabetes: A Systematic Review of Literature and Meta-analysis","volume":"20","author":"Park","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.diabres.2022.109825_b0280","first-page":"24","article-title":"Selecting the Appropriate Continuous Glucose Monitoring System - a Practical Approach","volume":"14","author":"Adolfsson","year":"2018","journal-title":"Eur Endocrinol"},{"issue":"2","key":"10.1016\/j.diabres.2022.109825_b0285","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2337\/diaspect.21.2.112","article-title":"Continuous glucose monitoring: the future of diabetes management","volume":"21","author":"Burge","year":"2008","journal-title":"Diabetes Spectrum"},{"issue":"9","key":"10.1016\/j.diabres.2022.109825_b0290","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/dia.2019.0142","article-title":"Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes","volume":"21","author":"Hilliard","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"Suppl 4","key":"10.1016\/j.diabres.2022.109825_b0295","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/S1262-3636(11)70971-5","article-title":"Is continuous glucose monitoring (CGM) for everyone? To whom should CGM be prescribed and how?","volume":"37","author":"Riveline","year":"2011","journal-title":"Diabetes Metab"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722006374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722006374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:21:43Z","timestamp":1759173703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722006374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":59,"alternative-id":["S0168822722006374"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109825","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and economic outcomes of continuous glucose monitoring system (CGMS) in patients with diabetes mellitus: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109825"}}